Related Experiment Video

Updated: Mar 26, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

28.8K

[Intrauterine growth restriction--diagnosis and treatment]

Małgorzata Radoń-Pokracka, Hubert Huras, Robert Jach

    Przeglad Lekarski
    |January 29, 2016
    PubMed

    Insights

    Intrauterine fetal growth restriction (IUGR) is a primary cause of low birth weight, leading to stillbirths and neonatal deaths. This review summarizes current obstetric guidelines for managing IUGR.

    Area of Science:

    • Obstetrics and Gynecology
    • Neonatal Health
    • Fetal Medicine

    Background:

    • Low birth weight (LBW) affects 3-10% in developed and 15-20% in developing countries.
    • Intrauterine fetal growth restriction (IUGR) is the main cause of LBW.
    • LBW contributes significantly to stillbirths (69.6%) and neonatal deaths (66.4%).

    Purpose of the Study:

    • To review scientific data and summarize current guidelines on intrauterine fetal growth restriction (IUGR).
    • To provide obstetricians with updated information on managing IUGR.

    Main Methods:

    • Literature review of scientific data.
    • Synthesis of guidelines from major obstetric organizations (ACOG, RCOG, SOGC).
    • Inclusion of findings from key trials: DIGITAT, PORTO, and TRUFFLE.

    Main Results:

    • The review consolidates current evidence-based recommendations for IUGR management.
    • Key clinical trial data informs the summarized guidelines.
    • Focus on practical application for obstetricians.

    Conclusions:

    • Accurate diagnosis and timely management of IUGR are critical for improving neonatal outcomes.
    • Adherence to updated guidelines can reduce LBW-related mortality and morbidity.
    • Continued research and guideline updates are essential in fetal medicine.

    More Related Videos

    A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis06:19

    A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

    Published on: January 7, 2018

    11.0K
    High Frequency Ultrasound for the Analysis of Fetal and Placental Development In Vivo06:43

    High Frequency Ultrasound for the Analysis of Fetal and Placental Development In Vivo

    Published on: November 8, 2018

    11.1K

    Related Concept Videos

    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    5.5K
    Intrauterine Drug Delivery Systems01:21

    Intrauterine Drug Delivery Systems

    Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
    127
    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    4.5K